The Impact of Charcot-Marie-Tooth Disease in the Real World
Sponsor: ACMT-Rete per la malattia di Charcot-Marie-Tooth OdV
This observational or N/A phase trial investigates Charcot-Marie-Tooth Disease and is currently completed. ACMT-Rete per la malattia di Charcot-Marie-Tooth OdV leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Dec 2024 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Jul 2023 — Dec 2023 [monthly]
Recruiting
▶ Show 6 earlier versions
-
May 2022 — Jul 2023 [monthly]
Recruiting
-
Jan 2021 — May 2022 [monthly]
Recruiting
-
Jun 2020 — Jan 2021 [monthly]
Recruiting
-
Jan 2020 — Jun 2020 [monthly]
Recruiting
-
Feb 2019 — Jan 2020 [monthly]
Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Recruiting
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ACMT-Rete per la malattia di Charcot-Marie-Tooth OdV
- CMT France
- Charcot-Marie-Tooth Association
- Charcot-Marie-Tooth UK
- Federación Española de Enfermedades Neuromusculares
- Hereditary Neuropathy Foundation
- Pharnext S.C.A.
- Vitaccess Ltd
For direct contact, visit the study record on ClinicalTrials.gov .